Low-density lipoprotein (LDL), which includes apolipoprotein A-I (apoAI-LDL) as a novel marker of coronary artery disease.

Low-density lipoprotein (LDL), which includes apolipoprotein A-I (apoAI-LDL) as a novel marker of coronary artery disease. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Low-density lipoprotein (LDL), which includes apolipoprotein A-I (apoAI-LDL) as a novel marker of coronary artery disease. Abstract Text:

BACKGROUND: Serum low-density lipoprotein (LDL), which includes apolipoprotein A-I (apoAI-LDL) may be generated by oxidization in the serum of patients with coronary artery disease (CAD). We determine the utility of the serum apoAI-LDL level as a novel coronary risk factor. METHODS: We measured serum apoAI-LDL in 473 consecutive patients who underwent diagnostic coronary angiography. Serum levels of apoAI-LDL were assayed by a newly developed ELISA. RESULTS: The patients consisted of 84 with unstable angina (UA), 259 with stable CAD, and 130 without CAD (control). The serum level of apoAI-LDL was higher in CAD patients than in the control group (31.4 (22.1-41.4) microg/ml vs. 24.6 (18.4-29.2) microg/ml, respectively, p<0.001), as well as in patients with UA compared to those with stable CAD 44.5 (35.8-51.9) microg/ml vs. 27.1 (19.5-35.6) microg/ml, respectively, p<0.0001) (data are expressed as the median (25th-75th percentiles)). By logistic regression analysis, only apoAI-LDL was independent, being significantly able to predict CAD (odds ratio: 1.50, 95% CI: 1.23-1.82, p<0.001), and differentiate unstable angina (odds ratio: 1.80, 95% CI: 1.48-2.17, p<0.001) after controlling for classical risk factors. CONCLUSION: The serum level of apoAI-LDL, a newly identified component of oxidized LDL, may be a more sensitive marker of CAD and acute coronary syndrome than CRP.

Low-density lipoprotein (LDL), which includes apolipoprotein A-I (apoAI-LDL) as a novel marker of coronary artery disease. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Low-density lipoprotein (LDL), which includes apolipoprotein A-I (apoAI-LDL) as a novel marker of coronary artery disease. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Clinica chimica acta; international journal of cli

VOLUME: 397

Page Numbers: 42-7

Journal Abbreviation: Clin. Chim. Acta

ISSN: 0009-8981

DAY: 18

MONTH: 07

YEAR: 2008

Low-density lipoprotein (LDL), which includes apolipoprotein A-I (apoAI-LDL) as a novel marker of coronary artery disease. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 1302422

Low-density lipoprotein (LDL), which includes apolipoprotein A-I (apoAI-LDL) as a novel marker of coronary artery disease. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Low-density lipoprotein (LDL), which includes apolipoprotein A-I (apoAI-LDL) as a novel marker of coronary artery disease. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Low-density lipoprotein (LDL), which includes apolipoprotein A-I (apoAI-LDL) as a novel marker of coronary artery disease.

AFFILIATION: The Cardiovascular Institute. Tokyo, Japan.

Country: Netherlands

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Clin Chim Acta

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Low-density lipoprotein LDL, which includes apolipoprotein A-I apoAI-LDL as a novel marker of coronary artery disease Related Publications

• "Black hole" restenosis after sirolimus-eluting stent implantation.
• A double-blind placebo needle for acupuncture research.
• A new immobilized cell system with protection against toxic solvents.
• Bilirubin helps to overcome the two-cell block in mouse oocyte cultures.
• Bioactive analogues and drug delivery systems of vasoactive intestinal peptide (VIP) for the treatment of asthma/COPD.
• Clinical effects of Bifidobacterium preparations on pediatric intractable diarrhea.
• Constituents from the leaves of Nelumbo nucifera stimulate lipolysis in the white adipose tissue of mice.
• Correlation of the Period Length of Circadian Rhythms with the Length of Immaturity in Paramecium bursaria.
• Impaired alveolization in mice deficient in membrane-type matrix metalloproteinase 1 (MT1-MMP).
• Low-density lipoprotein (LDL), which includes apolipoprotein A-I (apoAI-LDL) as a novel marker of coronary artery disease.
• Matrix mineralization as a trigger for osteocyte maturation.
• Metabolic mode peculiar to Meckel's cartilage: immunohistochemical comparisons of hypoxia-inducible factor-1alpha and glucose transporters in developing endochondral bones in mice.
• Nucleobase catalysis in ribozyme mechanism.
• Osteoclast differentiation in ectopic bone formation induced by recombinant human bone morphogenetic protein 2 (rhBMP-2).
• Pre-operative drilling simulation method for dental implant treatment.
• Prospective outcomes of comminuted periarticular metacarpal and phalangeal fractures treated using a titanium plate system.
• Reduced thymic size and numbers of splenic CD4+ and CD8+ cells in artificially reared mouse pups.
• Synthesis of new UV-B light absorbents: (Acetylphenyl)glycosides with antioxidant activities.
• [A case report of annuloaortic ectasia with coarctation of the aorta and "high take off" of the right coronary artery]